Cannabidiol Intermediate

Cannabidiol Intermediate (CAS 22972-51-6) is manufactured directly by Suzhou Everfortune Co., Ltd. as a synthesis intermediate for cannabidiol (CBD), the non-psychoactive cannabis-derived compound used in treating certain rare childhood epilepsy syndromes such as Dravet and Lennox-Gastaut syndrome, as well as anxiety, pain, and inflammation. It is offered at pharmaceutical grade with samples available, distributed across Asia, North and South America, Europe, Australasia, the Middle East, and Africa.